Estrogen, inflammation and cardiovascular risk in women: a critical appraisal
- 31 March 2004
- journal article
- review article
- Published by Elsevier BV in Trends in Endocrinology & Metabolism
- Vol. 15 (2), 66-72
- https://doi.org/10.1016/j.tem.2004.01.005
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- Breast cancer and hormone-replacement therapy in the Million Women StudyThe Lancet, 2003
- Prospective Randomized Study of Effects of Unopposed Estrogen Replacement Therapy on Markers of Coagulation and Inflammation in Postmenopausal WomenJournal of Clinical Endocrinology & Metabolism, 2001
- Effects of Estrogen Replacement on the Progression of Coronary-Artery AtherosclerosisNew England Journal of Medicine, 2000
- Both Raloxifene and Estrogen Reduce Major Cardiovascular Risk Factors in Healthy Postmenopausal WomenArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- Hormone replacement therapy and sensitive C-reactive protein concentrations in women with type-2 diabetesThe Lancet, 1999
- Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal WomenJAMA, 1998
- The Long-Term Effects of Oral and Transdermal Postmenopausal Hormone Replacement Therapy on Nitric Oxide, Endothelin-1, Prostacyclin, and ThromboxaneFertility and Sterility, 1998
- Postmenopausal Estrogen and Progestin Use and the Risk of Cardiovascular DiseaseNew England Journal of Medicine, 1996
- Vascular endothelium: An integrator of pathophysiologic stimuli in atherosclerosisThe American Journal of Cardiology, 1995
- Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidencePreventive Medicine, 1991